Slezavit as a Component of Neuroprotective Therapy for Primary Open-Angle Glaucoma

dc.contributor.authorKhuddieva Nargiza Yuldashevna
dc.date.accessioned2026-01-02T11:32:16Z
dc.date.issued2022-06-18
dc.description.abstractThe term "glaucoma" unites a large group of eye diseases of various origins with a progradient, chronic course. As a rule, glaucoma occurs with an increase in the level of intraocular pressure (IOP; with the exception of glaucoma with the so-called low (pseudonormal) pressure), the development of optic neuropathy, which is manifested by characteristic changes in the retinal fibers of the retina of the optic nerve head, and progressively worsening visual functions with the appearance of typical visual field defects
dc.formatapplication/pdf
dc.identifier.urihttps://geniusjournals.org/index.php/emrp/article/view/1726
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/77304
dc.language.isoeng
dc.publisherGenius Journals
dc.relationhttps://geniusjournals.org/index.php/emrp/article/view/1726/1541
dc.sourceEurasian Medical Research Periodical; Vol. 9 (2022): EMRP; 93-95
dc.source2795-7624
dc.subjectGlaucoma
dc.subjecteye
dc.titleSlezavit as a Component of Neuroprotective Therapy for Primary Open-Angle Glaucoma
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
yuldashevna_2022_slezavit_as_a_component_of_neuroprotecti.pdf
item.page.filesection.size
198.81 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections